- Report
- October 2024
- 184 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- October 2024
- 197 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1194EUR$1,250USD£998GBP
- Report
- March 2025
- 50 Pages
Global
From €2531EUR$2,650USD£2,116GBP
- Report
- March 2025
- 50 Pages
Global
From €2531EUR$2,650USD£2,116GBP
Cysteamine is a drug used to treat endocrine and metabolic disorders. It is a cystine-depleting agent, meaning it reduces the amount of cystine in the body, which can help reduce the symptoms of certain disorders. Cysteamine is used to treat cystinosis, a rare genetic disorder that affects the kidneys, eyes, and other organs. It is also used to treat other metabolic disorders, such as homocystinuria and hypermethioninemia. Cysteamine is available in both oral and intravenous forms.
Cysteamine is a relatively new drug, and the market is still developing. It is primarily used in the United States, Europe, and Japan, but is becoming increasingly available in other countries. The drug is typically prescribed by endocrinologists and other specialists.
Companies in the cysteamine market include Raptor Pharmaceuticals, Horizon Pharma, and Shire Pharmaceuticals. Show Less Read more